Has Karen Mitchell, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,347 in general payments to Karen Mitchell, MD across 130 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Karen Mitchell, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Karen Mitchell, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Karen Mitchell, MD

Dermatopathology · Marlborough, MANPI 1619986114

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,986 of the $3,347 with a category attached, or 89.2%. It is spread thinly across 23 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,211, 3.4 times the $352 reported in 2019.

$3,347in general payments, 2019–2025

Across 130 payments — averaging $25.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lilly USA, LLC$544
Johnson & Johnson$468
LEO Pharma Inc.$373
AbbVie$316
E.r. Squibb & Sons, L.L.C.$288
Sun Pharmaceutical Industries Inc.$266
plus $1K from 17 others

What the payments were for

Food & beverage$2,98689%
Education$36111%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lilly USA, LLC	21	$544
Johnson & Johnson	9	$468
LEO Pharma Inc.	25	$373
AbbVie	18	$316
E.r. Squibb & Sons, L.L.C.	11	$288
Sun Pharmaceutical Industries Inc.	10	$266
UCB, Inc.	4	$154
Revance Therapeutics, Inc.	1	$146
Avanos Medical	1	$125
Novartis	5	$115
Sanofi	3	$98
Amgen	3	$83
Galderma Laboratories, L.p.	4	$67
Arcutis Biotherapeutics, Inc.	3	$54
Botanix SB Inc	2	$43
Dermavant Sciences, Inc.	2	$38
Dermira, Inc.	2	$29
Incyte Corporation	1	$28
Alnylam Pharmaceuticals Inc.	1	$28
VYNE Pharmaceuticals Inc.	1	$24
Organogenesis Inc.	1	$21
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$20
Almirall LLC	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few dermatopathology providers in Massachusettsto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$80,299

Medicare patients

268

Services billed

1,009

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Metronidazole	29	$2,351
Clindamycin Phosphate	14	$965
Betamethasone Dipropionate	12	$631
ValacyclovirValacyclovir Hcl	14	$547
CiclopiroxCiclopirox Olamine	29	$474
Fluocinonide	13	$376
Triamcinolone Acetonide	43	$292
Ketoconazole	15	$231
Mupirocin	24	$100
Cephalexin	11	$40

Paid to pharmacies, not to this prescriber.

Other dermatopathology in Marlborough

Lynn DrakeBoston$46K
Artur ZembowiczBurlington$5K
Yvana CespedesLexington$1K
Rosalynn NazarianBoston$1K
Yvonne HinesAttleboro$750
Olympia KovichPlainville$221
Mary TanNeedham$158
Adriano PirisNeedham$95
Mandana MahmoodiNeedham$28
Alejandro Peralta SolerNeedham$28

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →